SS Innovations International (NASDAQ:SSII) Shares Up 7.5% - Should You Buy?

Key Points

• SSII shares rose 7.5% to about $2.87, though trading volume was 96% below the stock’s average daily volume.
• Analyst sentiment remains negative: SSII has a consensus “Sell” rating and a $7.00 target price, while Weiss Ratings maintained its sell rating and Wall Street Zen upgraded the stock to hold.
• The company reported a quarterly loss of $0.01 per share on $13.94 million in revenue, alongside negative profitability metrics; CEO Srivastava Sudhir also sold roughly $100,000 worth of shares.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report)'s stock price rose 7.5% during trading on Tuesday. The company traded as high as $2.77 and last traded at $2.8710. 3,100 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 70,945 shares. The stock had previously closed at $2.67.

Analyst Ratings Changes

SSII has been the subject of a number of research reports. Weiss Ratings reissued a "sell (e+)" rating on shares of SS Innovations International in a research note on Friday, July 17th. Wall Street Zen raised SS Innovations International from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Sell" and a consensus target price of $7.00.

SS Innovations International Stock Performance

The business's fifty day moving average price is $3.44 and its two-hundred day moving average price is $3.85. The stock has a market capitalization of $553.06 million, a P/E ratio of -46.00 and a beta of -1.79.

SS Innovations International (NASDAQ:SSII - Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.01) EPS for the quarter. SS Innovations International had a negative return on equity of 26.77% and a negative net margin of 23.73%.The company had revenue of $13.94 million during the quarter.

Insider Activity

In other news, CEO Srivastava Sudhir sold 33,333 shares of SS Innovations International stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $3.00, for a total value of $99,999.00. Following the completion of the transaction, the chief executive officer owned 108,520,928 shares in the company, valued at approximately $325,562,784. The trade was a 0.03% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hedge Funds Weigh In On SS Innovations International

Several large investors have recently modified their holdings of SSII. IFC & Insurance Marketing Inc. lifted its position in SS Innovations International by 47.7% in the first quarter. IFC & Insurance Marketing Inc. now owns 16,730 shares of the company's stock worth $84,000 after buying an additional 5,400 shares during the last quarter. Eversept Partners LP bought a new position in SS Innovations International during the fourth quarter valued at $428,000. Finally, Inspire Investing LLC increased its position in SS Innovations International by 26.4% during the first quarter. Inspire Investing LLC now owns 104,624 shares of the company's stock valued at $523,000 after acquiring an additional 21,851 shares during the last quarter.

SS Innovations International Company Profile

SS Innovations International Inc is a medical technology company focused on developing and commercializing robotic-assisted surgical systems. Its principal platform, the SSI MANTRA surgical robotic system, is designed to support minimally invasive procedures by providing surgeons with enhanced visualization, precision and instrument control.

The company also develops related surgical instruments, accessories and technologies intended for use across a range of specialties. Its products are aimed at hospitals and surgical teams seeking robotic assistance for procedures while supporting operating-room efficiency and improved patient care.

SS Innovations was founded by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.